NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough-to-treat lymphoma in japanese patients
Disease control OngoingThis study tests the safety and effectiveness of tafasitamab alone or combined with other drugs (lenalidomide, parsaclisib, or R-CHOP) in about 72 Japanese adults with Non-Hodgkin lymphoma, including diffuse large B-cell lymphoma. The goal is to find the best doses and see if the…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Jun 17, 2026 04:12 UTC
-
New drug cocktail shows promise for tough lymphoma cases
Disease control OngoingThis study tests a combination of drugs (glofitamab, atezolizumab, or polatuzumab vedotin, plus a pre-treatment dose of obinutuzumab) in adults with B-cell non-Hodgkin's lymphoma that has come back or not responded to prior treatments. The goal is to find the safest dose and see …
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Scientists collect tumor samples to unlock secrets of blood cancers
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from up to 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers grow and differ from normal cells. The goal is to better understand the disea…
Matched conditions: NON-HODGKINS LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 17, 2026 04:08 UTC